ETX.L

e-therapeutics plc [ETX.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ETX.L Stock Summary

Top 10 Correlated ETFs

ETX.L


Top 10 Correlated Stocks

ETX.L


In the News

ETX.L Financial details

Company Rating
Sell
Market Cap
71.44M
Income
-19.15M
Revenue
635K
Book val./share
0.05
Cash/share
0.04
Dividend
-
Dividend %
-
Employees
34
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
-15.35
Forward P/E
-
PEG
-1.35
P/S
369.54
P/B
2.49
P/C
275
P/FCF
-20.25
Quick Ratio
19.47
Current Ratio
22.2
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-6.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
0.66%
Revenue last 5Y
60.93%
Revenue Q/Q
-11.11%
EPS Q/Q
20%
-
-
-
-
SMA20
-19.37%
SMA50
-14.68%
SMA100
13.49%
Inst Own
-
Inst Trans
-
ROA
-15%
ROE
70%
ROC
-0.21%
Gross Margin
100%
Oper. Margin
-3158%
Profit Margin
-2479%
Payout
-
Shs Outstand
584.34M
Shs Float
242.45M
-
-
-
-
Target Price
-
52W Range
8.0-24.0
52W High
-54.17%
52W Low
+37.5%
RSI
35.65
Rel Volume
0.51
Avg Volume
329.53K
Volume
169.64K
Perf Week
-12.21%
Perf Month
-29.49%
Perf Quarter
-8.18%
Perf Half Y
-13.73%
-
-
-
-
Beta
0.478
-
-
Volatility
0.52%, 1.6%
Prev Close
-1.35%
Price
11
Change
-8.33%

ETX.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-01-31

Metric History 2019-01-312020-01-312021-01-312022-01-31 2023-01-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.01-0.01-0.01-0.02-0.02
Operating cash flow per share
-0.01-0.01-0.01-0.02-0.01
Free cash flow per share
-0.01-0.01-0.01-0.02-0.01
Cash per share
0.020.020.050.050.09
Book value per share
0.030.020.040.060.06
Tangible book value per share
0.020.020.040.060.06
Share holders equity per share
0.030.020.040.060.06
Interest debt per share
00000
Market cap
14.1M10.08M71M163.59M86.51M
Enterprise value
8.2M6.31M58M152.93M55.12M
P/E ratio
-3.53-4.3-19.27-20.28-10.46
Price to sales ratio
320.4722.11223.99342.97182.13
POCF ratio
-3.81-5.01-21.25-21.11-11.47
PFCF ratio
-3.8-4.97-20.81-18.78-11.16
P/B Ratio
2.072.245.115.92.62
PTB ratio
2.072.245.115.92.62
EV to sales
186.2813.84182.97320.62116.04
Enterprise value over EBITDA
-1.62-2.26-13.26-16.36-5.64
EV to operating cash flow
-2.21-3.14-17.36-19.74-7.31
EV to free cash flow
-2.21-3.11-17-17.56-7.11
Earnings yield
-0.28-0.23-0.05-0.05-0.1
Free cash flow yield
-0.26-0.2-0.05-0.05-0.09
Debt to equity
-0.030.0200.020.02
Debt to assets
-0.030.0100.020.02
Net debt to EBITDA
1.171.352.971.143.21
Current ratio
10.3917.5633.1419.1521.3
Interest coverage
000-954.2-445.17
Income quality
0.930.860.910.960.91
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
33.752.726.68.257.33
Research and developement to revenue
83.484.618.5312.8115.21
Intangibles to total assets
0.020.020.0100.01
Capex to operating cash flow
00.010.020.120.03
Capex to revenue
-0.18-0.04-0.22-2.02-0.44
Capex to depreciation
-0.15-0.17-0.87-4.99-0.45
Stock based compensation to revenue
1.180.081.331.030.33
Graham number
0.090.060.090.150.15
ROIC
-0.94-0.51-0.26-0.28-0.26
Return on tangible assets
-0.54-0.5-0.26-0.27-0.24
Graham Net
0.020.020.050.050.09
Working capital
6.64M4.32M13.72M27.11M32.41M
Tangible asset value
6.68M4.39M13.8M27.62M32.81M
Net current asset value
6.64M4.3M13.72M26.82M32.41M
Invested capital
-0.030.0200.020.02
Average receivables
1.29M854.5K709.5K1.27M1.73M
Average payables
386K95K52.5K124.5K314K
Average inventory
-1.29M-558K000
Days sales outstanding
9.26K474.66951.071.31K1.35K
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
0.040.770.380.280.27
Payables turnover
00000
Inventory turnover
00000
ROE
-0.59-0.52-0.27-0.29-0.25
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-07-31 for Q2

Metric History 2021-07-312022-01-312022-07-312023-01-31 2023-07-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.01-0.01-0.01-0.01-0.01
Operating cash flow per share
-0.01-0.01-0.01-0.01-0.01
Free cash flow per share
-0.01-0.01-0.01-0.01-0.01
Cash per share
0.060.050.040.060.04
Book value per share
0.060.050.050.060.05
Tangible book value per share
0.060.050.050.060.05
Share holders equity per share
0.060.050.050.060.05
Interest debt per share
00000
Market cap
126.07M172.38M113.47M89.91M101.51M
Enterprise value
94.46M161.47M92.15M58.51M76.75M
P/E ratio
-11.3-8.16-7.44-5.04-4.54
Price to sales ratio
264.290384.65499.48634.41
POCF ratio
-41.56-36.57-24.09-31.72-15.5
PFCF ratio
-40.96-30.61-23.43-30.9-15.25
P/B Ratio
3.826.164.662.723.69
PTB ratio
3.826.164.662.723.69
EV to sales
198.030312.39325.06479.69
Enterprise value over EBITDA
-27.29-27.41-21.37-10.72-11.46
EV to operating cash flow
-31.14-34.25-19.57-20.65-11.72
EV to free cash flow
-30.69-28.67-19.02-20.11-11.53
Earnings yield
-0.02-0.03-0.03-0.05-0.06
Free cash flow yield
-0.02-0.03-0.04-0.03-0.07
Debt to equity
00.020.020.010
Debt to assets
00.020.020.010
Net debt to EBITDA
9.131.854.945.753.7
Current ratio
39.5919.3122.6421.322.2
Interest coverage
0-606.5-379.58-516.73-1.74K
Income quality
1.090.891.240.641.17
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
3.0805.859.7611.29
Research and developement to revenue
5.27010.5922.7833.28
Intangibles to total assets
000.010.010.01
Capex to operating cash flow
0.010.190.030.030.02
Capex to revenue
-0.090-0.45-0.42-0.68
Capex to depreciation
-1.02-5.28-0.55-0.34-0.4
Stock based compensation to revenue
0.5300.66-0.230.37
Graham number
0.090.110.090.10.1
ROIC
-0.09-0.18-0.15-0.14-0.21
Return on tangible assets
-0.08-0.18-0.15-0.13-0.2
Graham Net
0.060.050.040.060.04
Working capital
32.84M27.36M23.66M32.41M27.06M
Tangible asset value
32.92M27.87M24.18M32.81M27.23M
Net current asset value
32.84M27.07M23.57M32.41M27.06M
Invested capital
00.020.020.010
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
315.280723.66879.51.6K
Days payables outstanding
0570.5200393.87
Days of inventory on hand
00000
Receivables turnover
0.2900.120.10.06
Payables turnover
00.16000.23
Inventory turnover
00000
ROE
-0.08-0.19-0.16-0.14-0.2
Capex per share
00000

ETX.L Frequently Asked Questions

What is e-therapeutics plc stock symbol ?

e-therapeutics plc is a GB stock and trading under the symbol ETX.L

What is e-therapeutics plc stock quote today ?

e-therapeutics plc stock price is $11 today.

Is e-therapeutics plc stock public?

Yes, e-therapeutics plc is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap